Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Leases (2022 - 2025)

Cellebrite DI has reported Current Leases over the past 4 years, most recently at $4.0 million for Q4 2025.

  • Quarterly results put Current Leases at $4.0 million for Q4 2025, down 3.13% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (down 3.13% YoY), and the annual figure for FY2025 was $4.0 million, down 3.13%.
  • Current Leases for Q4 2025 was $4.0 million at Cellebrite DI, down from $4.1 million in the prior quarter.
  • Over the last five years, Current Leases for CLBT hit a ceiling of $5.0 million in Q4 2022 and a floor of $4.0 million in Q4 2025.
  • Median Current Leases over the past 4 years was $4.5 million (2023), compared with a mean of $4.5 million.
  • Biggest five-year swings in Current Leases: dropped 0.62% in 2023 and later dropped 17.04% in 2024.
  • Cellebrite DI's Current Leases stood at $5.0 million in 2022, then dropped by 0.62% to $5.0 million in 2023, then dropped by 17.04% to $4.1 million in 2024, then fell by 3.13% to $4.0 million in 2025.
  • The last three reported values for Current Leases were $4.0 million (Q4 2025), $4.1 million (Q4 2024), and $5.0 million (Q4 2023) per Business Quant data.